BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Velez JCQ, Therapondos G, Juncos LA. Reappraising the spectrum of AKI and hepatorenal syndrome in patients with cirrhosis.Nat Rev Nephrol. 2020;16:137-155. [PMID: 31723234 DOI: 10.1038/s41581-019-0218-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Nassar M, Nso N, Medina L, Ghernautan V, Novikov A, El-Ijla A, Soliman KM, Kim Y, Alfishawy M, Rizzo V, Daoud A. Liver kidney crosstalk: Hepatorenal syndrome. World J Hepatol 2021; 13(9): 1058-1068 [PMID: 34630874 DOI: 10.4254/wjh.v13.i9.1058] [Reference Citation Analysis]
2 Kovvuru K, Carbajal N, Pakanati AR, Thongprayoon C, Hansrivijit P, Boonpheng B, Pattharanitima P, Nissaisorakarn V, Cheungpasitporn W, Kanduri SR. Renal manifestations of hepatitis E among immunocompetent and solid organ transplant recipients. World J Hepatol 2022; 14(3): 516-524 [DOI: 10.4254/wjh.v14.i3.516] [Reference Citation Analysis]
3 Sheng X, Chen W, Xu Y, Lin F, Cao H. Higher Mean Corpuscular Hemoglobin Concentration is Associated with Worse Prognosis of Hepatorenal Syndrome: A Multicenter Retrospective Study. Am J Med Sci 2021:S0002-9629(21)00356-6. [PMID: 34624233 DOI: 10.1016/j.amjms.2021.06.026] [Reference Citation Analysis]
4 Huang Y, Cai J, Ha F, Guo B, Xin S, Duan Z, Han T. Characteristics of acute kidney injury and its impact on outcome in patients with acute-on-chronic liver failure. BMC Gastroenterol 2022;22:231. [PMID: 35545763 DOI: 10.1186/s12876-022-02316-8] [Reference Citation Analysis]
5 Chaney A. A Review for the Practicing Clinician: Hepatorenal Syndrome, a Form of Acute Kidney Injury, in Patients with Cirrhosis. Clin Exp Gastroenterol 2021;14:385-96. [PMID: 34675586 DOI: 10.2147/CEG.S323778] [Reference Citation Analysis]
6 Wang YJ, Li JH, Guan Y, Xie QH, Hao CM, Wang ZX. Diabetes mellitus is a risk factor of acute kidney injury in liver transplantation patients. Hepatobiliary Pancreat Dis Int 2021;20:215-21. [PMID: 33752999 DOI: 10.1016/j.hbpd.2021.02.006] [Reference Citation Analysis]
7 Rui Y, Li S, Luan F, Li D, Liu R, Zeng N, Yan L. Several Alkaloids in Chinese Herbal Medicine Exert Protection in Acute Kidney Injury: Focus on Mechanism and Target Analysis. Oxidative Medicine and Cellular Longevity 2022;2022:1-16. [DOI: 10.1155/2022/2427802] [Reference Citation Analysis]
8 Weng F. Comment on "Urinary NGAL as a Diagnostic and Prognostic Marker for Acute Kidney Injury in Cirrhosis". Clin Transl Gastroenterol 2021;12:e00382. [PMID: 34251358 DOI: 10.14309/ctg.0000000000000382] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Gowda YH, Jagtap N, Karyampudi A, Rao NP, Deepika G, Sharma M, Gupta R, Tandan M, Ramchandani M, John P, Kulkarni A, Kumar P, Bhaware B, Turpati MV, Reddy ND. Fractional Excretion of Sodium and Urea in Differentiating Acute Kidney Injury Phenotypes in Decompensated Cirrhosis. Journal of Clinical and Experimental Hepatology 2021. [DOI: 10.1016/j.jceh.2021.09.019] [Reference Citation Analysis]
10 Scurt FG, Bose K, Canbay A, Mertens PR, Chatzikyrkou C. [Chronic kidney injury in patients with liver diseases - Reappraising pathophysiology and treatment options]. Z Gastroenterol 2021;59:560-79. [PMID: 33728618 DOI: 10.1055/a-1402-1502] [Reference Citation Analysis]
11 Zhong HJ, Zhuang YP, Zhang YT, Xu SP, Hong MF, He XX. Distinguishing between the complications of Wilson disease-related cirrhosis and HBV-related cirrhosis. Curr Med Res Opin 2021;:1-7. [PMID: 34665066 DOI: 10.1080/03007995.2021.1993160] [Reference Citation Analysis]
12 Ducatti L, Haddad LBP, Meyer A, Nacif LS, Arantes RM, Martino RB, Rocha-Santos V, Waisberg DR, Pinheiro RS, D Albuquerque LAC, Andraus W. CIRRHOTIC PATIENTS WITH ACUTE KIDNEY INJURY (AKI) HAVE HIGHER MORTALITY AFTER ABDOMINAL HERNIA SURGERY. Arq Bras Cir Dig 2022;34:e1622. [PMID: 35019134 DOI: 10.1590/0102-672020210002e1622] [Reference Citation Analysis]
13 Matyas C, Haskó G, Liaudet L, Trojnar E, Pacher P. Interplay of cardiovascular mediators, oxidative stress and inflammation in liver disease and its complications. Nat Rev Cardiol 2021;18:117-35. [PMID: 32999450 DOI: 10.1038/s41569-020-0433-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
14 Pang Y, Zhang PC, Lu RR, Li HL, Li JC, Fu HX, Cao YW, Fang GX, Liu BH, Wu JB, Zhou JY, Zhou Y. Andrade-Oliveira Salvianolic Acid B Modulates Caspase-1-Mediated Pyroptosis in Renal Ischemia-Reperfusion Injury via Nrf2 Pathway. Front Pharmacol 2020;11:541426. [PMID: 33013384 DOI: 10.3389/fphar.2020.541426] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
15 Yu Y, Xie S, Wang K, Zhang F, Jiang C, Qiu C, Zhu J, Shen W. Perfusion Analysis of Kidney Injury in Rats With Cirrhosis Induced by Common Bile Duct Ligation Using Arterial Spin Labeling MRI. J Magn Reson Imaging 2021. [PMID: 34499757 DOI: 10.1002/jmri.27917] [Reference Citation Analysis]
16 Rondon-berrios H, Velez JCQ. Hyponatremia in Cirrhosis. Clinics in Liver Disease 2022. [DOI: 10.1016/j.cld.2022.01.001] [Reference Citation Analysis]
17 Kwong A, Kim WR, Kwo PY, Wang U, Cheng X. Feasibility and Effectiveness of Norepinephrine Outside the Intensive Care Setting for Treatment of Hepatorenal Syndrome. Liver Transpl 2021;27:1095-105. [PMID: 33837624 DOI: 10.1002/lt.26065] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Eknoyan G, Epstein M. Hepatorenal syndrome: a historical appraisal of its origins and conceptual evolution. Kidney Int 2021;99:1321-30. [PMID: 33781792 DOI: 10.1016/j.kint.2021.02.037] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Basthi Mohan P, Nagaraju SP, Rangaswamy D, Musunuri B, Prabhu Attur R, Bhat G, Shailesh, Shetty S. Urinary neutrophil gelatinase-associated lipocalin: Acute kidney injury in liver cirrhosis. Clin Chim Acta 2021;523:339-47. [PMID: 34666028 DOI: 10.1016/j.cca.2021.10.015] [Reference Citation Analysis]
20 Chaney A. Hepatorenal Syndrome: A Case Study of Outpatient to Inpatient to Recovery. Clin Liver Dis (Hoboken) 2021;17:81-4. [PMID: 33680441 DOI: 10.1002/cld.1038] [Reference Citation Analysis]
21 Varghese V, Rivera MS, Alalwan AA, Alghamdi AM, Gonzalez ME, Velez JCQ. Diagnostic Utility of Serial Microscopic Examination of the Urinary Sediment in Acute Kidney Injury. Kidney360 2021;2:182-91. [DOI: 10.34067/kid.0004022020] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Belcher JM, Parada XV, Simonetto DA, Juncos LA, Karakala N, Wadei HM, Sharma P, Regner KR, Nadim MK, Garcia-Tsao G, Velez JCQ, Parikh SM, Chung RT, Allegretti AS; HRS-HARMONY study investigators. Terlipressin and the Treatment of Hepatorenal Syndrome: How the CONFIRM Trial Moves the Story Forward. Am J Kidney Dis 2021:S0272-6386(21)00890-8. [PMID: 34606933 DOI: 10.1053/j.ajkd.2021.08.016] [Reference Citation Analysis]
23 Li Y, Liu X, Jiang Y, Wan K, Liu W, Ou Y, Bai J, You Y, Hu F, Xu Z, Bie P, Zhang C, Zhang L. Low preoperative prealbumin predicts the prevalence of complications following liver transplantation. BMC Gastroenterol 2021;21:233. [PMID: 34022800 DOI: 10.1186/s12876-021-01818-1] [Reference Citation Analysis]
24 Bejjani A, Zhang Y, Behrens A, Murray B, Shah N. Droxidopa in the Management of Hepatorenal Syndrome. J Pharm Pract 2022;:8971900221087974. [PMID: 35426352 DOI: 10.1177/08971900221087974] [Reference Citation Analysis]
25 Fang Y, Zhu H, Gao C, Gu Y, Liu Y, Yuan Y, Wu X. Value of shear wave elastography in predicting hepatorenal syndrome in patients with liver cirrhosis and ascites. Int J Clin Pract 2021;75:e14811. [PMID: 34490949 DOI: 10.1111/ijcp.14811] [Reference Citation Analysis]
26 Ali B, Salim A, Alam A, Zuberi BF, Ali Z, Azam Z, Kamani L, Farooqi JI, Salih M, Nawaz AA, Chaudhry AA, Hashmi ZY, Siddique M. HEP-Net opinion on the management of ascites and its complications in the setting of decompensated cirrhosis in the resource constrained environment of Pakistan. Pak J Med Sci 2020;36:1117-32. [PMID: 32704299 DOI: 10.12669/pjms.36.5.2407] [Reference Citation Analysis]
27 Velez JCQ. Hepatorenal Syndrome Type 1: From Diagnosis Ascertainment to Goal-Oriented Pharmacologic Therapy. Kidney360 2022;3:382-95. [PMID: 35373127 DOI: 10.34067/KID.0006722021] [Reference Citation Analysis]